Navigation Links
SPECT provides high-quality images of small tumors
Date:6/15/2009

TORONTOA new study shows that combining high resolution and high sensitivity collimation provides better quality images when using single photon emission computed tomography (SPECT) scans, said researchers at SNM's 56th Annual Meeting. Collimatorsdevices that filter a stream of rays so that only those traveling parallel to a specified direction are allowed throughare used in SPECT because it is not yet possible to focus radiation with such short wavelengths into an image with the use of lenses. Using the two types of collimation in tandem is especially effective for better imaging of small tumors, the study indicates.

"SPECT is an important tool in molecular imaging because of its ability to provide accurate images of what is going on in the body without the need for invasive procedures such as surgery," said Roel Van Holen, researcher in the department of electronics and information systems of Ghent University, Ghent, Belgium, and lead author of the study. "However, researchers have had to make tradeoffs in SPECT image quality, especially in imaging very small tumors. Our research is exciting because it shows that combining high-resolution and high-energy collimators can improve SPECT's ability to image small tumors."

Researchers have established that SPECT image quality generally improves when using collimators with higher sensitivity than traditional low-energy high-resolution (LEHR) collimators. However, this is not the case when small tumors are being imaged. In these cases, LEHR actually provides better images.

The new study combined a high-resolution collimator with a high-sensitivity collimator. A dual-head SPECT camera with three different collimator settings was simulated using the GATE Monte Carlo simulator. The results indicated that SPECT image quality was better with the mixed collimation than it was by using only high-resolution or only high-sensitivity collimation.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Page: 1

Related medicine news :

1. Prospect Therapeutics In Vitro Studies Demonstrate that GCS-100 Drug Binds to and Blocks the Effects of Galectin-3
2. 63 percent of RA patients suffer psychiatric disorders, with depressive spectrum conditions most likely
3. Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Issuance and Sale of Stock
4. Senators Specter and Casey Vote to Protect Americas Kids from Tobacco
5. Spectrum Names Katherine Maynard Chief Operating Officer
6. Best and Brightest Forum on Medical Innovation Brings Senator Arlen Specter, U.S. Representative Anna Eshoo, and Innovation Leaders Together in Washington, D.C., This Week
7. FluxData, Inc. Introduces New Multispectral Camera with Embedded PC104 Computer
8. Ludwig Institute of Cancer Research Ltd., Brussels Branch, Issues Statement Concerning Prospect Therapeutics Incs. GCS-100 Molecule
9. Respected Surgeon Receives Emmy Nomination
10. Senators Arlen Specter and John Cornyn Will Discuss Medicare Issues at American Association for Homecare Legislative Conference, June 2-3, 2009
11. Delaware Urologic Associate's, Dr. Peter J. Muench, Presents Advances in Incontinence Treatment with a New Perspective and Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... The OSHA Training ... Institute Education Center headquartered in Northern California, has issued an important reminder to ... their worksites. Employers with workers exposed to high temperatures should establish a ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... "FCPX editors ... customizable inside of Final Cut Pro X," said Christina Austin - CEO of Pixel ... style. Final Cut Pro X users can now reveal the media of ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... health professionals, announced today its affiliation with Tennessee Counseling Association. This ... the network of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... transport experience for the millions of people who require these medical transport services ... industry through the use of technology. Now, SmartEMS has put forth an industry-changing ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals plc ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ... (Eastern Daylight Time). As previously announced on ... a definitive merger agreement under which Jazz Pharmaceuticals has ...
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
Breaking Medicine Technology: